USPTO Examiner PIATESKI ERIN M - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17129283CATHETER-BASED HEART SUPPORT SYSTEM AND METHOD OF IMPLANTING THEREOFDecember 2020March 2023Allow2700YesNo
17073085LINEAR CARDIAC ASSIST PULSATILE PUMPOctober 2020July 2023Allow3301YesNo
17069011TISSUE EXTRACTION DEVICES AND METHODSOctober 2020October 2022Allow2410NoNo
17065211DELIVERY DEVICES AND METHODS FOR LEADLESS CARDIAC DEVICESOctober 2020January 2023Allow2720NoNo
17033482INTRAVASCULAR BLOOD PUMP SYSTEMS AND METHODS OF USE AND CONTROL THEREOFSeptember 2020March 2023Allow3020NoNo
17027432NEUROMODULATION DEVICE AND METHOD FOR USESeptember 2020June 2023Allow3310NoNo
17026135CIRCUITS FOR MOBILE ECG SYSTEMSeptember 2020June 2022Allow2100YesNo
17023977AUTOMATIC METHOD TO DELINEATE OR CATEGORIZE AN ELECTROCARDIOGRAMSeptember 2020June 2021Allow920NoNo
17013581MEDICAL DEVICES WITH LAYERED CONDUCTIVE ELEMENTS AND METHODS FOR MANUFACTURING THE SAMESeptember 2020February 2022Allow1800YesNo
16978275SYSTEMS AND METHODS FOR OPERATING AN IMPLANTABLE MEDICAL DEVICE BASED UPON SENSED POSTURE INFORMATIONSeptember 2020April 2023Allow3111NoNo
17010264SYSTEM AND METHOD FOR TEMPORAL SPARSE PROMOTING IMAGING OF CARDIAC ACTIVATIONSeptember 2020February 2022Allow1700NoNo
16947899NON-INVASIVE PREDICTION OF RISK FOR SUDDEN CARDIAC DEATHAugust 2020January 2022Allow1700NoNo
16965487VENTRICULAR ASSISTANCE ASSEMBLY WITH STABILIZED CARDIAC PUMPJuly 2020June 2022Allow2210NoNo
16937537SLEEP APNEA TREATMENT DEVICEJuly 2020June 2022Abandon2310NoNo
16887231SYSTEMS AND METHODS OF UNATTENDED TREATMENT OF A SUBJECT'S HEAD OR NECKMay 2020March 2023Allow3300YesNo
16880392LOW EQUIVALENT SERIES RESISTANCE RF FILTER CIRCUIT BOARD FOR AN ACTIVE IMPLANTABLE MEDICAL DEVICEMay 2020April 2022Allow2210NoNo
16871942SYNCHRONIZING NEUROELECTRIC MEASUREMENTS WITH DIAGNOSTIC CONTENT PRESENTATIONMay 2020November 2023Abandon4210NoNo
16652737DIGITALLY ADJUSTABLE PHRENIC NERVE STIMULATOR SYSTEMApril 2020September 2022Allow3030NoNo
16816006CHARGING DEVICE WITH OFF-CENTER COILMarch 2020December 2022Allow3330NoNo
16811998METHOD AND APPARATUS FOR TREATING SLEEP APNEAMarch 2020March 2023Abandon3611NoNo
16810121FRAME FOR BLOOD PUMPMarch 2020May 2022Allow2710NoNo
16810172IMPELLER HOUSINGMarch 2020January 2022Allow2200NoNo
16810086VENTRICULAR ASSIST DEVICE WITH STABILIZED IMPELLERMarch 2020January 2022Allow2200NoNo
16808657ELECTRODE UNIT, PULSE WAVE MEASUREMENT UNIT, AND PULSE WAVE MEASUREMENT DEVICEMarch 2020June 2023Allow4011NoNo
16805515FACILITATING TELEMETRY DATA COMMUNICATION SECURITY BETWEEN AN IMPLANTABLE DEVICE AND AN EXTERNAL DEVICEFebruary 2020May 2023Allow3830YesNo
16803231SYSTEMS FOR MEDICAL DEVICE INTERACTIONSFebruary 2020November 2021Allow2100NoNo
16641169DRIVE SHAFT COVER WITH A HEAT CONDUCTING PARTFebruary 2020December 2022Allow3420NoNo
16639255BLOOD PUMPFebruary 2020January 2022Allow2400YesNo
16788175SYSTEM FOR NEUROMODULATIONFebruary 2020May 2023Allow3940YesNo
16787470ELECTROCARDIOGRAM ANALYSIS APPARATUS AND ELECTROCARDIOGRAM SYSTEMFebruary 2020November 2022Allow3320YesNo
16752371POSITION SENSITIVE LINGUAL MUSCLE STIMULATION SYSTEM FOR OBSTRUCTIVE SLEEP APNEAJanuary 2020August 2021Allow1910NoNo
16752390OBSTRUCTIVE SLEEP APNEA PATIENT PROGRAMMER FOR IMPLANTABLE DEVICESJanuary 2020January 2023Allow3530YesNo
16752382SYSTEM AND METHOD FOR IMPROVED OBSTRUCTIVE SLEEP APNEA DIAGNOSTIC FOR IMPLANTABLE DEVICESJanuary 2020March 2022Abandon2510NoNo
16751631MOTOR DEVICES FOR MOTOR NERVE ROOT STIMULATIONJanuary 2020April 2022Abandon2610NoNo
16750354DISTAL TIP ELEMENT FOR A VENTRICULAR ASSIST DEVICEJanuary 2020October 2021Allow2100NoNo
16745008INFLOW CANNULA INCLUDING EXPANDABLE SLEEVE AND METHODS OF IMPLANTING SAMEJanuary 2020January 2022Allow2410YesNo
16737253ANTENNA CONFIGURATIONJanuary 2020August 2021Allow1900NoNo
16737601SYSTEMS AND METHODS FOR SPATIALLY SELECTIVE SPINAL CORD STIMULATIONJanuary 2020February 2022Allow2610YesNo
16730253SELECTIVE TERMINATION OF STIMULATION TO DELIVER POST-STIMULATION THERAPEUTIC EFFECTDecember 2019September 2021Allow2000NoNo
16724498NON-INVASIVE DEVICE FOR SYNCHRONIZING CHEST COMPRESSION AND VENTILATION PARAMETERS TO RESIDUAL MYOCARDIAL ACTIVITY DURING CARDIOPULMONARY RESUSCITATIONDecember 2019May 2022Allow2910YesNo
16709676WCD SYSTEM OPERABLE TO NOT ALARM WHEN DETECTED CARDIAC ARRHYTHMIAS ARE NOT VALIDATEDDecember 2019April 2022Allow2811YesNo
16707970METHODS AND DEVICES FOR CELLULAR ACTIVATIONDecember 2019July 2021Allow1910YesNo
16620304HEART SUPPORT SYSTEM, CANNULA ARRANGEMENT FOR A HEART SUPPORT SYSTEM AND USE OF THE HEART SUPPORT SYSTEMDecember 2019June 2022Abandon3010NoNo
16705226Wearable Heartbeat and Breathing Waveform Continuous Monitoring SystemDecember 2019October 2022Allow3420YesNo
16694710RELAY INTERFACE FOR CONNECTING AN IMPLANTED MEDICAL DEVICE TO AN EXTERNAL ELECTRONICS DEVICENovember 2019February 2022Allow2710YesNo
16615690ARTIFICIAL INTELLIGENCE-BASED INTERFERENCE RECOGNITION METHOD FOR ELECTROCARDIOGRAMNovember 2019December 2021Allow2510NoNo
16673745DIPOLAR ANTENNA SYSTEM AND RELATED METHODSNovember 2019July 2022Allow3220YesNo
16671821SELECTION OF OPTIMAL CHANNEL FOR RATE DETERMINATIONNovember 2019November 2021Allow2510YesNo
16658618ELECTRODE ASSEMBLIES FOR NEUROSTIMULATION TREATMENTOctober 2019August 2021Allow2210YesNo
16658368DUAL PROPHYLACTIC AND ABORTIVE ELECTRICAL STIMULATIONOctober 2019March 2021Allow1700NoNo
16655419ORAL MUSCLE TRAININGOctober 2019June 2023Allow4440NoNo
16655198SYSTEM FOR COUPLING A CARDIAC AUTONOMOUS CAPSULE TO A TOOL FOR IMPLANTING THE SAMEOctober 2019November 2021Allow2510NoNo
16597067Implantable Medical Devices and Systems with Communication/Sensing Based on Near Infrared SignalsOctober 2019July 2021Allow2110NoNo
16578373SYSTEMS AND METHODS FOR TRANSSEPTAL DELIVERY OF PERCUTANEOUS VENTRICULAR ASSIST DEVICES AND OTHER NON-GUIDEWIRE BASED TRANSVASCULAR THERAPEUTIC DEVICESSeptember 2019September 2020Allow1211YesNo
16575721MONITORING AND TRACKING BIPOLAR ABLATIONSeptember 2019November 2021Allow2610NoNo
16494952PHYSIOLOGICAL INFORMATION WAVEFORM PROCESSING METHOD, PROGRAM, COMPUTER READABLE STORAGE MEDIUM, AND PHYSIOLOGICAL INFORMATION WAVEFORM PROCESSING APPARATUSSeptember 2019March 2022Allow3020YesNo
16570499INSTRUMENT DRIVE UNIT INCLUDING LEAD SCREW RAILSSeptember 2019March 2021Allow1800NoNo
16494042ENDOVASCULAR DEVICE NAVIGATIONSeptember 2019December 2022Abandon3910NoNo
16568954WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) SYSTEM INFORMING PATIENT THAT IT WILL NOT SHOCK RESPONSIVE TO JUST-SELF-TERMINATED CARDIAC ARRHYTHMIASeptember 2019October 2021Allow2510NoNo
16569205METHOD AND APPARATUS FOR IMPROVING COGNITIVE PERFORMANCESeptember 2019December 2021Allow2710NoNo
16492208APPARATUSES, METHODS, AND SYSTEMS FOR CONTACT FORCE SENSINGSeptember 2019March 2023Allow4220YesNo
16551807BLADDER STORAGE ANOMALY ASSESSMENTAugust 2019March 2021Allow1900YesNo
16483855CHARACTERIZING BEHAVIOR OF ANATOMICAL STRUCTURESAugust 2019January 2023Allow4120YesNo
16523297METHOD AND APPARATUS FOR VERIFYING BRADYCARDIA/ASYSTOLE EPISODES VIA DETECTION OF UNDER-SENSED EVENTSJuly 2019October 2021Allow2711YesNo
16522648AUTOMATIC METHOD TO DELINEATE OR CATEGORIZE AN ELECTROCARDIOGRAMJuly 2019July 2020Allow1120YesNo
16515270MOTOR DEVICES FOR MOTOR NERVE ROOT STIMULATIONJuly 2019October 2019Allow300YesNo
16450895Method and Apparatus for the Capture of Intra-cellular ActivityJune 2019December 2022Allow4200NoNo
16446612METHODS AND SYSTEMS FOR TREMOR REDUCTIONJune 2019March 2022Allow3320NoNo
16445036APPARATUS AND METHOD FOR DIFFERENTIATING WIDE COMPLEX HEART BEATSJune 2019June 2021Allow2410YesNo
16427044MULTI-SENSOR BASED CARDIAC STIMULATIONMay 2019July 2021Allow2610YesNo
16417625APPARATUSES AND METHODS FOR TRANSDERMAL ELECTRICAL STIMULATION OF NERVES TO MODIFY OR INDUCE A COGNITIVE STATEMay 2019September 2021Allow2810NoNo
16408910IDENTIFY INSULATION BREACH USING ELECTROGRAMSMay 2019November 2021Allow3020NoYes
16392541WEARABLE MEDICAL (WM) SYSTEM MONITORING ECG SIGNAL OF AMBULATORY PATIENT FOR HEART CONDITIONApril 2019March 2021Allow2300YesNo
16388233SYSTEMS AND METHODS FOR DETECTING ARRHYTHMIASApril 2019August 2021Allow2820YesNo
16341453System and method for monitoring personal health and a method for treatment of autonomic nervous system related dysfunctionsApril 2019December 2020Allow2020YesNo
16341717FILTERING DEVICE FOR RECORDING ELECTROPHYSIOLOGICAL SIGNALSApril 2019May 2021Allow2510NoNo
16376250SYSTEM AND METHOD FOR ONSET/OFFSET CAPTUREApril 2019May 2023Allow4960NoYes
16338550BLOOD GLUCOSE MEASUREMENT DEVICE, BLOOD GLUCOSE CALCULATION METHOD, AND BLOOD GLUCOSE CALCULATION PROGRAMApril 2019May 2021Allow2510YesNo
16363970POSITIONING METHOD AND APPARATUS FOR DELIVERING VAPOR TO THE UTERUSMarch 2019June 2021Allow2710YesNo
16360321NEUROMODULATION FOR NEUROINFLAMMATION TREATMENTS WITH PARAMETERS CONTROLLED USING BIOMARKERSMarch 2019February 2021Allow2310NoNo
16359583SYSTEM AND METHOD OF ADJUSTING THE COMPLIANCE VOLTAGE IN A NEUROMODULATION DEVICEMarch 2019November 2020Allow1900NoNo
16359278TIMED ENERGY DELIVERYMarch 2019February 2021Allow2310NoNo
16353901FILTERING ALGORITHM FOR ASSESSING COMMUNICATIONS WIRELESSLY RECEIVED BY AN IMPLANTABLE MEDICAL DEVICEMarch 2019October 2020Allow1900NoNo
16352147METHOD AND APPARATUS FOR INTERLOCKING STIMULATION PARAMETERS FOR NEUROMODULATIONMarch 2019February 2021Allow2310YesNo
16292227SYSTEM TO DELIVER ADAPTIVE EPIDURAL AND/OR SUBDURAL ELECTRICAL SPINAL CORD STIMULATION TO FACILITATE AND RESTORE LOCOMOTION AFTER A NEUROMOTOR IMPAIRMENTMarch 2019August 2021Allow2920YesNo
16279548COCHLEAR IMPLANTFebruary 2019June 2021Abandon2810NoNo
16279440IMPLANT PACKAGE FOR COCHLEAR PROSTHESIS AND METHOD OF IMPLANTING THE SAMEFebruary 2019May 2021Abandon2710NoNo
16279316MULTI-CHANNEL ELECTRIC STIMULATOR FOR NEURAL IMPLANTFebruary 2019June 2021Abandon2810NoNo
16326332Tissue Anchors with Flexible Tips for Insertion into the Pericardial CavityFebruary 2019May 2021Abandon2710NoNo
16325179MEDICAL DEVICES WITH LAYERED CONDUCTIVE ELEMENTS AND METHODS FOR MANUFACTURING THE SAMEFebruary 2019September 2020Allow1920YesNo
16241119SELECTION OF OPTIMAL CHANNEL FOR RATE DETERMINATIONJanuary 2019August 2020Allow1900NoNo
16227610Flow Rate Control for a Cooled Medical Probe AssemblyDecember 2018March 2021Allow2720NoNo
16226823SYSTEMS AND METHODS FOR VIBRATION-BASED COMMUNICATIONDecember 2018November 2021Allow3530NoNo
16228426ELECTROPHYSIOLOGICAL RIPPLE MAPPING VISUALIZATION METHODDecember 2018August 2021Allow3230NoNo
16311309Systems Methods and Devices for Closed Loop Stimulation To Enhance Stroke RecoveryDecember 2018June 2021Allow3020NoNo
16210491Maternity Monitoring System and MethodDecember 2018April 2021Abandon2910NoNo
16062610IMPLANTABLE PROBE COMPRISING A SLEEVE, PARTICULARLY FOR THE STIMULATION OF A NERVE, AND MANUFACTURING METHOD FOR SAID SLEEVENovember 2018September 2020Allow2710YesNo
16191431PHYSIOLOGICAL SIGNAL WIRELESS TRANSMISSION SYSTEM AND THE OPERATING METHOD THEREOFNovember 2018July 2021Allow3230NoNo
16190468IMPLANTABLE ELECTRODE ARRAYNovember 2018October 2020Allow2310NoNo
16301513BODY CONDITION PREDICTING DEVICE, METHOD, AND PROGRAMNovember 2018August 2021Allow3330NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PIATESKI, ERIN M.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
1
(20.0%)
Examiner Reversed
4
(80.0%)
Reversal Percentile
90.5%
Higher than average

What This Means

With a 80.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
5
(50.0%)
Not Allowed After Appeal Filing
5
(50.0%)
Filing Benefit Percentile
83.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner PIATESKI, ERIN M - Prosecution Strategy Guide

Executive Summary

Examiner PIATESKI, ERIN M works in Art Unit 3792 and has examined 234 patent applications in our dataset. With an allowance rate of 82.5%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 28 months.

Allowance Patterns

Examiner PIATESKI, ERIN M's allowance rate of 82.5% places them in the 57% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by PIATESKI, ERIN M receive 1.67 office actions before reaching final disposition. This places the examiner in the 31% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PIATESKI, ERIN M is 28 months. This places the examiner in the 69% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +16.4% benefit to allowance rate for applications examined by PIATESKI, ERIN M. This interview benefit is in the 56% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 35.5% of applications are subsequently allowed. This success rate is in the 81% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 42.5% of cases where such amendments are filed. This entry rate is in the 66% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 85.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 67% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 64.3% of appeals filed. This is in the 44% percentile among all examiners. Of these withdrawals, 44.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 35.3% are granted (fully or in part). This grant rate is in the 22% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 53% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.